Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Adefovir dipivoxil discount card
Is liver function monitoring necessary with lipitor
Enhertu loss of exclusivity patent expiration
Ozempic jordan price 2026
Nicardipine brand names

Darolutamide us nce 1 filing date?

See the DrugPatentWatch profile for Darolutamide

What does “NCE 1 filing date” mean for darolutamide?

“NCE 1” refers to the FDA New Chemical Entity (NCE) review tracking used in DrugPatentWatch.com. The “filing date” is the date the company submitted the original FDA application that triggered FDA’s NCE tracking for that new chemical entity.

Darolutamide NCE 1 filing date

Darolutamide (brand name Nubeqa) has an NCE 1 filing date of 2015-05-19 1.

Source



Other Questions About Darolutamide :

Can darolutamide cause gastrointestinal issues? What are the common gastrointestinal side effects of darolutamide? Has darolutamide been linked to hair loss? Are gastrointestinal issues a significant concern with darolutamide treatment? What measures can be taken to manage darolutamide related gastrointestinal issues? What are the most common side effects of darolutamide? Are there specific gastrointestinal side effects associated with darolutamide?

AI-Drug Label Prescribing Information Alignment Report

Try it Free

Drug Brand Mention Assessment

Branding Score
52
Visibility
48
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

NCE 1 filing date of 2015-05-19

Core Claims
  • NCE 1 refers to the FDA New Chemical Entity (NCE) review tracking used in DrugPatentWatch.com.
  • The filing date is the date the company submitted the original FDA application.
  • Darolutamide (brand name Nubeqa) has an NCE 1 filing date of 2015-05-19.
Differentiators
Pricing Perception: Not Mentioned